{"nctId":"NCT00412087","briefTitle":"Vitamin D Status of Pregnant Women and Their Children in Eau Claire, South Carolina","startDateStruct":{"date":"2007-01"},"conditions":["Vitamin D Deficiency","Pregnancy"],"count":564,"armGroups":[{"label":"Cholecalciferol 2000 IU","type":"EXPERIMENTAL","interventionNames":["Drug: cholecalciferol (vitamin D3)","Drug: cholecalciferol"]},{"label":"Cholecalciferol 4000 IU","type":"EXPERIMENTAL","interventionNames":["Drug: cholecalciferol (vitamin D3)","Drug: cholecalciferol"]}],"interventions":[{"name":"cholecalciferol (vitamin D3)","otherNames":["vitamin D3"]},{"name":"cholecalciferol","otherNames":["Vitamin D3"]},{"name":"cholecalciferol","otherNames":["Vitamin D3"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nAim 1: Any mother who presents to her obstetrician or midwife at Eau Claire with confirmation of a singleton pregnancy will be eligible for enrollment in Aim 1.\n\nAim 2: If the mother also is \\<12 completed weeks of gestation, she will be eligible for participation of Aim 2 of the study. Mothers of diverse ethnic background (African-American, Asian, Caucasian, Asian and Hispanic) actively will be recruited. There are no age exclusion criteria.\n\nExclusion Criteria:\n\nAim 1: There are no exclusion criteria.\n\nAim 2: Mothers with pre-existing calcium, parathyroid conditions or who require chronic diuretic or cardiac medication therapy including calcium channel blockers will not be eligible for enrollment into the study. Mothers with active thyroid disease (e.g., Graves, Hashimoto's or thyroiditis) will not be eligible to participate in the study; however, mothers on thyroid supplement with normal serological parameters may participate in the study if they are without any other endocrine dysfunction. Mothers with diabetes will not be excluded from participation in the study as vitamin D deficiency appears linked with insulin resistance and may aggravate the maternal condition.","healthyVolunteers":true,"sex":"FEMALE","minimumAge":"16 Years","maximumAge":"45 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"25-hydroxyvitamin D at Visit 7","description":"25-hydroxyvitamin D at Visit 7, one month prior to delivery","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"36.7","spread":"14.9"},{"groupId":"OG001","value":"39.8","spread":"12.9"}]}]}]},{"type":"SECONDARY","title":"Parathyroid Hormone at Visit 7","description":"Intact parathyroid hormone at Visit 7, one month prior to delivery","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17.3","spread":"8.3"},{"groupId":"OG001","value":"14.3","spread":"6.9"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":5,"n":134},"commonTop":["Complications of Pregnancy"]}}}